Showcases Stock ranks Forex

Boston Scientific Corp (BSX)
33.6  0.05 (0.15%) 11-27 13:00
Open: 33.9 Pre. Close: 33.55
High: 33.9 Low: 33.44
Volume: 6,178,276 Market Cap: 48,113M
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 34.086 - 34.275 34.275 - 34.428
Low: 32.909 - 33.18 33.18 - 33.4
Close: 33.154 - 33.553 33.553 - 33.878
Stock Technical Analysis
Target: Six months: 43.23
One year: 46.14
Support: Support1: 32.99
Support2: 27.45
Resistance: Resistance1: 37.01
Resistance2: 39.50
Pivot: 35.58
Moving Averages: MA(5): 33.59
MA(20): 35.41
MA(100): 38.04
MA(250): 38.24
MACD: MACD(12,26): -1.01
Signal(12,26,9): -0.80
%K %D: %K(14,3): 10.09
%D(3): 8.32
RSI: RSI(14): 36.90
52-Week: High: 46.62
Low: 24.1
Change(%): -21.3
Average Vol(K): 3-Month: 1131980
10-Days: 1678411
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.

BSX has closed above bottom band by 23.9%. Bollinger Bands are 56.3% wider than normal. The large width of the bands suggest high volatility as compared to BSX's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
Fri, 27 Nov 2020
Why Is Boston Scientific (BSX) Down 1.5% Since Last Earnings Report? - Nasdaq

Wed, 25 Nov 2020
Analysts think Boston Scientific Corporation (NYSE:BSX) could rise 48.9% from current levels - Stocks Register

Wed, 25 Nov 2020
Boston Scientific Corporation (BSX) upgraded Issued by Wall Street Gurus - The News Heater

Mon, 23 Nov 2020
For Boston Scientific Corporation [BSX], Analyst sees a rise to $47. What next? - The DBT News

Fri, 20 Nov 2020
Boston Scientific Corporation (BSX) Just Got Our Attention | News Heater - The News Heater

Wed, 18 Nov 2020
Morgan Stanley Stick to Their Buy Rating for Boston Scientific Corp. -

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 1430.00
Shares Float (M) 1430.00
% Held by Insiders 0.22
% Held by Institutions 93.26
Shares Short (K) 12170
Shares Short Prior Month (K) 12920
Stock Financials
EPS 2.610
Book Value (p.s.) 10.870
Profit Margin 36.64
Operating Margin 9.85
Return on Assets (ttm) 2.2
Return on Equity (ttm) 29.3
Qtrly Rev. Growth -1.8
Gross Profit (p.s.) 5.336
Sales Per Share 7.070
EBITDA (p.s.) 1.483
Qtrly Earnings Growth
Operating Cash Flow (M) 1530.00
Levered Free Cash Flow (M) 2170.00
Stock Valuation
PE Ratio 12.87
PEG Ratio 2.68
Price to Book value 3.09
Price to Sales 4.75
Price to Cash Flow 31.40
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator